Peloton Therapeutics

Peloton Therapeutics is involved in discovering and developing novel drugs for cancer treatments. Peloton Therapeutics was founded with the aim of capitalizing on untapped biomedical breakthroughs. By engaging in productive collaborations with world-class scientific visionaries, Peloton has been able to create innovative medicines to address the unmet needs of patients afflicted with life-threatening diseases.
Peloton’s lead investigational therapy, PT2385, is in Phase 1 clinical development as a selective, potent, and orally bioavailable treatment for advanced clear cell renal cell carcinoma (ccRCC). Preclinical data supports the application of PT2385 in other oncology indications such as glioblastoma. In addition to its clinical program, Peloton has a strong discovery pipeline. ACSS2 is a metabolic target that is important for tumor growth under conditions of nutrient stress. 
In addition to its internal scientific expertise, Peloton has successfully cultivated relationships with several investigators at leading academic institutions to gain direct access to cutting-edge science.

Show more
TypeSubsidiary
Parent CompanyMerck Group
HQDallas, TX, US
Founded2011
Websitepelotontherapeutics.com
Cybersecurity ratingCMore
Peloton Therapeutics was founded in 2011 and is headquartered in Dallas, TX, US

Viewing summary data as a guest

Sign up for free to see all data

Peloton Therapeutics Office Locations

Peloton Therapeutics has offices in Dallas and San Francisco
Dallas, TX, US (HQ)
2330 Inwood Rd
San Francisco, CA, US
580 California Street, 580 California St suite 1658, 16th floor, San Francisco
Show all (2)

Peloton Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2011

Total Funding

$92.6 m

Investors

In total, Peloton Therapeutics had raised $92.6 m. Peloton Therapeutics is a subsidiary of Merck Group

Peloton Therapeutics Revenue

USDFY, 2017FY, 2018

General and administrative expense

4.7m5.5m

R&D expense

23.1m31.6m

Operating expense total

27.8m37.1m

EBIT

(27.8m)(37.1m)
USDFY, 2017FY, 2018

Cash

45.1m29.9m

Prepaid Expenses

612.0k915.0k

Current Assets

45.7m30.8m

PP&E

661.0k1.6m
USDFY, 2017FY, 2018

Net Income

(24.9m)(36.1m)

Depreciation and Amortization

394.0k503.0k

Accounts Payable

1.5m128.0k

Cash From Operating Activities

(23.1m)(33.2m)
USDFY, 2017

Financial Leverage

1.1 x
Show all financial metrics

Peloton Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

C

71/100

SecurityScorecard logo

Peloton Therapeutics Online and Social Media Presence

Embed Graph

Peloton Therapeutics Frequently Asked Questions

  • When was Peloton Therapeutics founded?

    Peloton Therapeutics was founded in 2011.

  • How many employees does Peloton Therapeutics have?

    Peloton Therapeutics has 55 employees.

  • Who are Peloton Therapeutics competitors?

    Competitors of Peloton Therapeutics include Revolution Medicines, Iovance Biotherapeutics and Pharmacyclics.

  • Where is Peloton Therapeutics headquarters?

    Peloton Therapeutics headquarters is located at 2330 Inwood Rd, Dallas.

  • Where are Peloton Therapeutics offices?

    Peloton Therapeutics has offices in Dallas and San Francisco.

  • How many offices does Peloton Therapeutics have?

    Peloton Therapeutics has 2 offices.